Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262210877 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Gavino Faa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy. Hauptthemen laut MEDLINE: Zinc, Homeostasis, Mental Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Zinc (Zn2+) is a trace element essential for its catalytic, antioxidant, and immunomodulatory roles extending to synaptic signalling in the central nervous system. In this narrative review, we aim to offer the reader evidence linking perturbations of the Zn2+ homeostasis, including deficiency, excess, or transportation anomalies, to neuropsychiatric conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BD). A targeted, unsystematic PubMed search followed by an extensive pearl-growing strategy was applied to further augment study selection based on the extensive expertise of study authors. Overall, most of the evidence currently available suggests a modest benefit for a Zn2+ supplement of around 25–30 mg/day as an augmentation to MDD treatment, with potential benefits of smaller magnitude in paediatric ADHD. Evidence for perturbations of Zn2+ as a biomarker of risk for these neuropsychiatric disorders remains unconvincing. The role of Zn2+ supplements in the treatment of the selected conditions remains largely unknown due to the lack of specific, randomised controlled trials conducted to explore their efficacy. The long-term safety, optimal doses for specific applications, and the exploration of possible biomarkers to stratify patient selection to identify the optimal candidate for Zn2+ supplements remain unanswered questions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
- Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.
- Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, 09124 Cagliari, Italy.
- Department of Economic, Psychological and Communication Sciences, Niccolò Cusano University, 00166 Rome, Italy.
- Forensic Psychiatry Unit, Department of Mental Health and Addiction, Health Agency of Cagliari, 09124 Cagliari, Italy.
- Department of Pharmacology, Dalhousie University, Halifax, NS B3K 6R8, Canada.
ORCID-Profile: Gavino Faa, Mara Lastretti, Mirko Manchia, Pasquale Paribello
Zitieren
APA
Faa, G., Meloni, C., Lastretti, M., Pinna, M., Manchia, M., & Paribello, P. (2025). Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210877
Vancouver
Faa G, Meloni C, Lastretti M, Pinna M, Manchia M, Paribello P. Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210877
BibTeX
@article{Faa2025,
author = {Faa, Gavino and Meloni, Carlotta and Lastretti, Mara and Pinna, Martina and Manchia, Mirko and Paribello, Pasquale},
title = {Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262210877}
}
EUVIMED